Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.71 USD | -0.41% | -3.60% | -7.51% |
Financials (USD)
Sales 2024 * | 1.29B | Sales 2025 * | 1.36B | Capitalization | 7.64B |
---|---|---|---|---|---|
Net income 2024 * | 235M | Net income 2025 * | 270M | EV / Sales 2024 * | 5.91 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.61 x |
P/E ratio 2024 * |
31.4
x | P/E ratio 2025 * |
28.3
x | Employees | 2,246 |
Yield 2024 * |
1.51% | Yield 2025 * |
1.51% | Free-Float | 61.43% |
Latest transcript on Dolby Laboratories, Inc.
1 day | -0.41% | ||
1 week | -3.60% | ||
Current month | +2.64% | ||
1 month | +0.64% | ||
3 months | -1.92% | ||
6 months | -8.13% | ||
Current year | -7.51% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Yeaman
CEO | Chief Executive Officer | 58 | 05-10-23 |
Robert Park
DFI | Director of Finance/CFO | 54 | 21-10-14 |
Yaron Levi
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Yeaman
CEO | Chief Executive Officer | 58 | 05-10-23 |
Peter Gotcher
CHM | Chairman | 64 | 03-05-31 |
Avadis Tevanian
BRD | Director/Board Member | 63 | 09-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.78% | 254 M€ | +13.10% | - | |
1.93% | 4 M€ | +22.07% | - | |
1.06% | 3 M€ | 0.00% | ||
0.99% | 14 M€ | +8.59% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 79.71 | -0.41% | 168,226 |
24-05-23 | 80.04 | -1.34% | 243,068 |
24-05-22 | 81.13 | -0.61% | 417,254 |
24-05-21 | 81.63 | -1.28% | 454,864 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.51% | 7.64B | |
-20.31% | 213B | |
-19.98% | 58.61B | |
-0.09% | 58.3B | |
-11.74% | 45.97B | |
+1.83% | 41.34B | |
-1.28% | 36.11B | |
-8.75% | 28.91B | |
+106.15% | 27.03B | |
+4.60% | 21.91B |
- Stock Market
- Equities
- DLB Stock